Direct comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax (R).

C Deal, JP Brown, R Recker, Richard Prince, DP Kiel, JM Alvaro-Gracia, LH De Gregorio, P Hadji, LC Hofbauer, H Wang, Michael Austin, R Newmark, C Libanati, RB Wagman, JS Martin, HG Bone

    Research output: Chapter in Book/Conference paperConference paper

    Original languageEnglish
    Title of host publicationARTHRITIS AND RHEUMATISM
    PagesS940-S940
    Volume58
    Publication statusPublished - 2008
    EventDirect comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax (R). -
    Duration: 1 Jan 2008 → …

    Conference

    ConferenceDirect comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax (R).
    Period1/01/08 → …

    Cite this